Teva Pharmaceutical Industries, DEGEVMA, denosumab-adet, Xgeva, Biosimilar, FDA Approval, Biosimilars

Tel Aviv, Israel, and Parsippany, New Jersey, September 28, 2026 Teva Pharmaceutical Industries Ltd. announced that the U.S. Food...